ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00821340
Recruitment Status : Completed
First Posted : January 13, 2009
Last Update Posted : April 10, 2018
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 29, 2016
  Actual Study Completion Date : January 1, 2017
Publications: